Recent work has highlighted the potential of genomic risk scores (GRS) for risk prediction of common diseases21–24. Genomic risk prediction has a notable advantage over established risk factors as it could be used to infer risk of disease from birth, thus allowing the initiation of preventive strategies before conventional risk factors manifest and their discriminative capacity begins to emerge.
